Paul A Friedman insider trades
Open-market stock purchases and sales by Paul A Friedman, Unknown at Prelude Therapeutics Inc, from SEC Form 4 filings since Jan 21, 2010.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +190%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | PRLD Prelude Therapeutics Inc | Bought (not open market) | — |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $396K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $355K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $438K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $507K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $628K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $79.2K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $324K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $21.8K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $154K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $692K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $1M |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $1.3M |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $707K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $440K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $1.3M |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $561K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $822K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $304K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $366K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $87.9K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $149K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $177K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $254K |
| Jan 9, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $261K |
Companies traded
- PRLD Prelude Therapeutics Inc: 1 buy, last Jun 9, 2026
- MDGL Madrigal Pharmaceuticals, Inc: 2 buys, 104 sales, last Jan 9, 2026
- ALXN Alexion Pharmaceuticals, Inc: other filings, last Jul 21, 2021
- INCY Incyte Corp: 2 buys, 30 sales, last May 26, 2020
- CERU Cerulean Pharma Inc: other filings, last Apr 3, 2017
- VSTM Verastem, Inc: 1 buy, last Jun 14, 2016
- SNTA Synta Pharmaceuticals Corp: other filings, last Jul 1, 2015
- AUXL Auxilium Pharmaceuticals Inc: 2 sales, last Jan 29, 2015
- DRTX Durata Therapeutics, Inc: other filings, last Nov 17, 2014